Liraglutide regulate osteogenesis-resorption via macrophage under compressive stress

Objectives Joint diseases always caused by mechanical pressure induced-inflammation and bone resorption. With advancing age, joint wear-and-tear intensifies while reparative capacity diminishes. Liraglutide is a common medication used to lower blood sugar and improve blood lipids, and it is widely used in elderly patients. This study investigated whether liraglutide (Lira) regulates macrophage-mediated bone metabolism under mechanical pressure and elucidated the molecular mechanisms. Methods RAW264.7 macrophages were exposed to varying pressures (1–3 g/cm 2 ) via custom-weighted glass coverslips. Cell viability was assessed by CCK-8 and Live/Dead staining. Cells were pretreated with 250 nmol/L Lira, and the expression of osteoclast-related (Piezo1, NFATc1, TRAP) and inflammation-related (TNF-α, iNOS, IL-1β, TRAF6, NF-κB/p-NF-κB) molecules was detected by qRT-PCR, immunofluorescence, and Western blotting. Conditioned media from treated macrophages were used to culture MC3T3-E1 pre-osteoblasts, and osteogenic markers (BMP2, RUNX2, ALP, OCN) were evaluated. Results Pressure at 2 g/cm 2 for 4 h optimally induced osteoclastogenesis and inflammation. Lira did not affect Piezo1 expression but significantly suppressed NFATc1 and TRAP at both mRNA and protein levels. Lira also inhibited the TRAF6-NF-κB pathway, reducing TNF-α, iNOS, and IL-1β expression. Conditioned media from Lira-treated macrophages significantly upregulated BMP2, RUNX2, ALP, and OCN in MC3T3-E1 cells, indicating indirect promotion of osteogenesis. Conclusion Liraglutide reverses pressure-induced bone metabolic imbalance through a triple mechanism: inhibiting osteoclastogenesis, attenuating inflammation, and indirectly promoting osteogenesis via macrophage modulation. This study provides the first evidence of liraglutide’s molecular network in regulating bone metabolism under mechanical stress, supporting its therapeutic potential in pressure-related degenerative joint diseases such as osteoarthritis and temporomandibular joint osteoarthritis.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-10-26
DOI
https://doi.org/10.3389/fphar.2026.1985291
Primary Topic
Bone Metabolism and Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Liraglutide regulate osteogenesis-resorption via macrophage under compressive stress

Xiaochen Men, Yuzhu He, Runze Kong, Difei Wu et al.
Frontiers in Pharmacology
Bone Metabolism and Diseases
article

Liraglutide regulate osteogenesis-resorption via macrophage under compressive stress

Xiaochen Men, Yuzhu He, Runze Kong, Difei Wu, Qitao Du, Shuang Liu
article en

Abstract

Objectives Joint diseases always caused by mechanical pressure induced-inflammation and bone resorption. With advancing age, joint wear-and-tear intensifies while reparative capacity diminishes. Liraglutide is a common medication used to lower blood sugar and improve blood lipids, and it is widely used in elderly patients. This study investigated whether liraglutide (Lira) regulates macrophage-mediated bone metabolism under mechanical pressure and elucidated the molecular mechanisms. Methods RAW264.7 macrophages were exposed to varying pressures (1–3 g/cm 2 ) via custom-weighted glass coverslips. Cell viability was assessed by CCK-8 and Live/Dead staining. Cells were pretreated with 250 nmol/L Lira, and the expression of osteoclast-related (Piezo1, NFATc1, TRAP) and inflammation-related (TNF-α, iNOS, IL-1β, TRAF6, NF-κB/p-NF-κB) molecules was detected by qRT-PCR, immunofluorescence, and Western blotting. Conditioned media from treated macrophages were used to culture MC3T3-E1 pre-osteoblasts, and osteogenic markers (BMP2, RUNX2, ALP, OCN) were evaluated. Results Pressure at 2 g/cm 2 for 4 h optimally induced osteoclastogenesis and inflammation. Lira did not affect Piezo1 expression but significantly suppressed NFATc1 and TRAP at both mRNA and protein levels. Lira also inhibited the TRAF6-NF-κB pathway, reducing TNF-α, iNOS, and IL-1β expression. Conditioned media from Lira-treated macrophages significantly upregulated BMP2, RUNX2, ALP, and OCN in MC3T3-E1 cells, indicating indirect promotion of osteogenesis. Conclusion Liraglutide reverses pressure-induced bone metabolic imbalance through a triple mechanism: inhibiting osteoclastogenesis, attenuating inflammation, and indirectly promoting osteogenesis via macrophage modulation. This study provides the first evidence of liraglutide’s molecular network in regulating bone metabolism under mechanical stress, supporting its therapeutic potential in pressure-related degenerative joint diseases such as osteoarthritis and temporomandibular joint osteoarthritis.

Frontiers in PharmacologyVol. 17
Dalian Medical University (CN), Dalian University (CN), Jinan Stomatological Hospital (CN), Affiliated Zhongshan Hospital of Dalian University (CN)
Openalex Percentile: Top 22%
Bone Metabolism and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon